Form4insider filings, from the source

SEC Form 3 · accession 0001209191-19-013869

Horizon Pharma plc · HZNP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeff Kent
Officer — See remarks
Period of report
Feb 20, 2019
Accepted (ET)
Feb 26, 2019 · 8:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———101,960D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee stock options (right to buy)F1$3.95holding————Jun 7, 2022Ordinary Shares20,000—D
Employee stock options (right to buy)F1$7.61holding————Jan 1, 2024Ordinary Shares18,000—D
Employee stock options (right to buy)F2$22.14holding————Mar 22, 2025Ordinary Shares53,666—D
Restricted Stock UnitsF3$0.00holding—————Ordinary Shares6,500—D
Restricted Stock UnitsF4$0.00holding—————Ordinary Shares20,000—D
Restricted Stock UnitsF5$0.00holding—————Ordinary Shares15,000—D
Restricted Stock UnitsF6$0.00holding—————Ordinary Shares13,400—D
Restricted Stock UnitsF7$0.00holding—————Ordinary Shares24,521—D

Explanation of responses

Remarks

Officer Title: SVP, Head of Medical Affairs & Outcomes Research.